Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

News   Mar 12, 2018 | Original Story by Tim Stephens for the university of California Santa Cruz.

 
Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.

 
 
 

RELATED ARTICLES

SpiderMass Device to Speed Up Cancer Surgery

News

A new proteomic assay called SpiderMass which heats water in human tissue to enable ion analysis will allow doctors to speed up cancer surgery by locating tumor biomarkers more quickly.

READ MORE

New Portable Malaria Screening Instrument Developed

News

A new prototype for a portable instrument capable of early-stage malaria detection has been developed by a team of researchers at the USC Viterbi School of Engineering.

READ MORE

Diamonds Could Decrease Cost of Imaging and Spectroscopy Devices

News

A new approach shows great promise for enhancing the signal from magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) using lasers without expensive magnets.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy